St. Jude Medical, Inc. (NYSE:STJ) reported its last earnings on Jul 20 BMO (BMO = before market open, AMC= after market close). The company will report its next earnings on Oct 19 – Oct 24 (Est.). The company reported the earnings of $1.06/Share in the last quarter where the estimated EPS by analysts was $1.06/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.
Many analysts are providing their Estimated Earnings analysis for St. Jude Medical, Inc. and for the current quarter 21 analysts have projected that the stock could give an Average Earnings estimate of $1.01/share. These analysts have also projected a Low Estimate of $0.96/share and a High Estimate of $1.04/share.
In case of Revenue Estimates, 21 analysts have provided their consensus Average Revenue Estimates for St. Jude Medical, Inc. as 1.5 Billion. According to these analysts, the Low Revenue Estimate for St. Jude Medical, Inc. is 1.46 Billion and the High Revenue Estimate is 1.52 Billion. The company had Year Ago Sales of 1.34 Billion.
These analysts also forecasted Growth Estimates for the Current Quarter for STJ to be 4.1%. They are projecting Next Quarter growth of 6.9%. For the next 5 years, St. Jude Medical, Inc. is expecting Growth of 10.92% per annum, whereas in the past 5 years the growth was 4.25% per annum.
Some buy side analysts are also providing their Analysis on St. Jude Medical, Inc., where 0 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 21 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)
When it comes to the Analysis of a Stock, Price Target plays a vital role. 17 Analysts reported that the Price Target for St. Jude Medical, Inc. might touch $89 high while the Average Price Target and Low price Target is $78.97 and $60 respectively.
To analyze a stock, one should look for Upgrades and Downgrades of a stock. St. Jude Medical, Inc. got Downgrade on 15-Jul-16 where investment firm Wedbush Downgrade the stock from Outperform to Neutral.
St. Jude Medical, Inc. closed its last trading session at $82.88 with the loss of -0.16%. The Market Capitalization of the company stands at 23.56 Billion. The Company has 52-week high of $84 and 52-week low of $48.83. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -0.61% where SMA50 and SMA200 are 2.74% and 25.53% respectively. The Company Touched its 52-Week High on Aug 8, 2016 and 52-Week Low on Feb 11, 2016.
The Relative Volume of the company is 0.83 and Average Volume (3 months) is 2.34 million. St. Jude Medical, Inc. P/E (price to earnings) ratio is 35.93 and Forward P/E ratio of 18.68.
The company shows its Return on Assets (ROA) value of 5.4%. The Return on Equity (ROE) value stands at 16.1%. While it’s Return on Investment (ROI) value is 9.3%.
While looking at the Stock’s Performance, St. Jude Medical, Inc. currently shows a Weekly Performance of -0.76%, where Monthly Performance is 0.9%, Quarterly performance is 7.89%, 6 Months performance is 54.18% and yearly performance percentage is 26.98%. Year to Date performance value (YTD perf) value is 35.28%. The Stock currently has a Weekly Volatility of 0.69% and Monthly Volatility of 0.67%.